Year of publication
Type of material
Licence
Language
1–20 of 992 hits
Sort by:
Sort by:
-
2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trial
Free accessTaylor & Francis Verlag | 2022|Keywords: metastatic castration-resistant prostate cancer -
11β-Hydroxyandrostenedione Returns to the Steroid Arena: Biosynthesis, Metabolism and Function
Free accessDOAJ | 2013|Keywords: castration resistant prostate cancer (CRPC) -
11β-Hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione
Elsevier | 2013|Keywords: Castration-resistant prostate cancer -
18F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging
Online Contents | 2010|Keywords: Castration-resistant prostate cancer -
68Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients
Free accessOnline Contents | 2019|Keywords: Castration resistant prostate cancer -
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
Free accessOnline Contents | 2021|Keywords: Metastatic castration-resistant prostate cancer (mCRPC) -
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
Free accessBASE | 2021|Keywords: Metastatic castration-resistant prostate cancer (mCRPC) -
177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)
Free accessDataCite | 2021|Keywords: Metastatic castration-resistant prostate cancer (mCRPC) -
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial
Online Contents | 2021|Keywords: Castration-resistant prostate cancer -
177Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Free accessDOAJ | 2021|Keywords: advanced metastatic castration-resistant prostate cancer -
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
Free accessOnline Contents | 2018|Keywords: Metastatic castration-resistant prostate cancer -
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
Online Contents | 2019|Keywords: Metastatic castration-resistant prostate cancer -
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer : pilot experience
DataCite | 2019|Keywords: Metastatic castration-resistant prostate cancer -
A 3-(4-nitronaphthen-1-yl) amino-benzoate analog as a bifunctional AKR1C3 inhibitor and AR antagonist: Head to head comparison with other advanced AKR1C3 targeted therapeutics
Elsevier | 2019|Keywords: castration resistant prostate cancer -
Ability of C‐reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel‐based chemotherapy
Wiley | 2012|Keywords: metastatic castration resistant prostate cancer -
Abiraterone acetate, a first-in-class CYP17 inhibitor, establishes a new treatment paradigm in castration-resistant prostate cancer
Taylor & Francis Verlag | 2012|Keywords: castration-resistant prostate cancer -
Abiraterone acetate and prednisolone for metastatic castration‐resistant prostate cancer failing androgen deprivation and docetaxel‐based chemotherapy: A phase II bridging study in Korean and Taiwanese patients
Wiley | 2014|Keywords: metastatic castration‐resistant prostate cancer -
Abiraterone acetate for castration resistant prostate cancer
Taylor & Francis Verlag | 2010|Keywords: castration resistant prostate cancer -
Abiraterone acetate for metastatic castration‐resistant prostate cancer after docetaxel failure: A randomized, double‐blind, placebo‐controlled phase 3 bridging study
Wiley | 2016|Keywords: castration‐resistant prostate cancer -
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database
Taylor & Francis Verlag | 2022|Keywords: Metastatic castration-resistant prostate cancer
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions:
full data search
or
title and abstract search
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
TIB AV portal
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
Specialised Information Service for Mobility and Transport Research (FID move)
Open Research Knowledge Graph (ORKG)
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Common Union Catalogue (GVK)
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.